Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Prosthetic Heart Valve Market, by End User
1.4.2 North America Prosthetic Heart Valve Market, by Product
1.4.3 North America Prosthetic Heart Valve Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Approvals and Trials
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Mar – 2021, Oct) Leading Players
Chapter 4. North America Prosthetic Heart Valve Market by End User
4.1 North America Hospitals & Cardiac Centers Market by Country
4.2 North America Ambulatory Surgical Centers & Others Market by Country
Chapter 5. North America Prosthetic Heart Valve Market by Product
5.1 North America Transcatheter Market by Country
5.2 North America Tissue Market by Country
5.3 North America Mechanical Market by Country
Chapter 6. North America Prosthetic Heart Valve Market by Country
6.1 US Prosthetic Heart Valve Market
6.1.1 US Prosthetic Heart Valve Market by End User
6.1.2 US Prosthetic Heart Valve Market by Product
6.2 Canada Prosthetic Heart Valve Market
6.2.1 Canada Prosthetic Heart Valve Market by End User
6.2.2 Canada Prosthetic Heart Valve Market by Product
6.3 Mexico Prosthetic Heart Valve Market
6.3.1 Mexico Prosthetic Heart Valve Market by End User
6.3.2 Mexico Prosthetic Heart Valve Market by Product
6.4 Rest of North America Prosthetic Heart Valve Market
6.4.1 Rest of North America Prosthetic Heart Valve Market by End User
6.4.2 Rest of North America Prosthetic Heart Valve Market by Product
Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.2.6 SWOT Analysis
7.3 Abbott Laboratories
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Acquisition and Mergers:
7.3.5.3 Approvals and Trials:
7.3.6 SWOT Analysis
7.4 Meril Life Sciences Private Limited
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Product Launches and Product Expansions:
7.5 Colibri Heart Valve LLC
7.5.1 Company Overview
7.6 Artivion, Inc. (CryoLife, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 TTK Healthcare Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 Edwards Lifesciences Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.5.2 Approvals and Trials:
7.9 JenaValve Technology, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Geographical Expansions:
7.10. Micro Interventional Devices, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals and Trials:
Unique Offerings 
